$CXW
CoreCivic, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024122939 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $491.6M
YoY Change 1.62%
Cost Of Revenue $370.8M
YoY Change -1.72%
Gross Profit $120.7M
YoY Change 13.5%
Gross Profit Margin 24.56%
Selling, General & Admin $41.16M
YoY Change 21.33%
% of Gross Profit 34.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $32.24M
YoY Change -0.88%
% of Gross Profit 26.7%
Operating Expenses $73.40M
YoY Change 10.46%
Operating Profit $47.34M
YoY Change 18.56%
Interest Expense $16.00M
YoY Change -10.56%
% of Operating Profit 33.8%
Other Income/Expense, Net $767.0K
YoY Change -1136.49%
Pretax Income $30.18M
YoY Change 54.56%
Income Tax $9.100M
% Of Pretax Income 30.15%
Net Earnings $21.10M
YoY Change 51.86%
Net Earnings / Revenue 4.29%
Basic Earnings Per Share $0.19
Diluted Earnings Per Share $0.19
COMMON SHARES
Basic Shares Outstanding 110.3M 110.3M
Diluted Shares Outstanding 110.3K

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.9M
YoY Change 4.0%
Cash & Equivalents $107.9M
Short-Term Investments
Other Short-Term Assets $43.43M
YoY Change -7.31%
Inventory
Prepaid Expenses
Receivables $264.8M
Other Receivables $0.00
Total Short-Term Assets $416.1M
YoY Change -0.92%
LONG-TERM ASSETS
Property, Plant & Equipment $2.067B
YoY Change -2.87%
Goodwill $4.844M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $231.3M
YoY Change -25.84%
Total Long-Term Assets $2.498B
YoY Change -5.69%
TOTAL ASSETS
Total Short-Term Assets $416.1M
Total Long-Term Assets $2.498B
Total Assets $2.914B
YoY Change -5.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $262.8M
YoY Change -9.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $11.95M
YoY Change -14.52%
Total Short-Term Liabilities $274.7M
YoY Change -9.75%
LONG-TERM LIABILITIES
Long-Term Debt $979.8M
YoY Change -7.18%
Other Long-Term Liabilities $79.16M
YoY Change -40.64%
Total Long-Term Liabilities $1.059B
YoY Change -10.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $274.7M
Total Long-Term Liabilities $1.059B
Total Liabilities $1.438B
YoY Change -10.72%
SHAREHOLDERS EQUITY
Retained Earnings -$259.3M
YoY Change -22.68%
Common Stock $1.735B
YoY Change -3.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.476B
YoY Change
Total Liabilities & Shareholders Equity $2.914B
YoY Change -5.04%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $21.10M
YoY Change 51.86%
Depreciation, Depletion And Amortization $32.24M
YoY Change -0.88%
Cash From Operating Activities $91.47M
YoY Change 9.27%
INVESTING ACTIVITIES
Capital Expenditures $18.06M
YoY Change 0.64%
Acquisitions
YoY Change
Other Investing Activities $4.634M
YoY Change 1212.75%
Cash From Investing Activities -$13.42M
YoY Change -23.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -28.16M
YoY Change 752.13%
NET CHANGE
Cash From Operating Activities 91.47M
Cash From Investing Activities -13.42M
Cash From Financing Activities -28.16M
Net Change In Cash 49.88M
YoY Change -20.59%
FREE CASH FLOW
Cash From Operating Activities $91.47M
Capital Expenditures $18.06M
Free Cash Flow $73.41M
YoY Change 11.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001070985
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16109
dei Entity Registrant Name
EntityRegistrantName
CORECIVIC, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1763875
dei Entity Address Address Line1
EntityAddressAddressLine1
5501 VIRGINIA WAY
dei Entity Address City Or Town
EntityAddressCityOrTown
BRENTWOOD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37027
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
263-3000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
CXW
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
110270512
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107850000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121845000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9714000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7111000
CY2024Q3 cxw Allowance For Doubtful Accounts Credit Loss Reserve
AllowanceForDoubtfulAccountsCreditLossReserve
4640000
CY2023Q4 cxw Allowance For Doubtful Accounts Credit Loss Reserve
AllowanceForDoubtfulAccountsCreditLossReserve
6827000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
264843000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
312174000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33713000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26304000
CY2024Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
7480000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
416120000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
474914000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1888112000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1821015000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2066702000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2114522000
CY2024Q3 us-gaap Other Real Estate
OtherRealEstate
194972000
CY2023Q4 us-gaap Other Real Estate
OtherRealEstate
201561000
CY2024Q3 us-gaap Goodwill
Goodwill
4844000
CY2023Q4 us-gaap Goodwill
Goodwill
4844000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
231304000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
309558000
CY2024Q3 us-gaap Assets
Assets
2913942000
CY2023Q4 us-gaap Assets
Assets
3105399000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
262750000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
285857000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
11952000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11597000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
274702000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
297454000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
979811000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1083476000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
13149000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
18315000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
90896000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
96915000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79164000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
131673000
CY2024Q3 us-gaap Liabilities
Liabilities
1437722000
CY2023Q4 us-gaap Liabilities
Liabilities
1627833000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110271000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110271000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112733000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112733000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1103000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1127000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1734371000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1785286000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-259254000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-308847000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1476220000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1477566000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2913942000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3105399000
CY2024Q3 us-gaap Revenues
Revenues
491558000
CY2023Q3 us-gaap Revenues
Revenues
483705000
us-gaap Revenues
Revenues
1482353000
us-gaap Revenues
Revenues
1405389000
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
370818000
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
377323000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1124656000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1093868000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41162000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33927000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
111537000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99218000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32240000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32526000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
96115000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
95183000
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3108000
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2710000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3108000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2710000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
447328000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
446486000
us-gaap Costs And Expenses
CostsAndExpenses
1335416000
us-gaap Costs And Expenses
CostsAndExpenses
1290979000
CY2024Q3 us-gaap Interest Expense
InterestExpense
15998000
CY2023Q3 us-gaap Interest Expense
InterestExpense
17886000
us-gaap Interest Expense
InterestExpense
51721000
us-gaap Interest Expense
InterestExpense
55305000
CY2024Q3 cxw Expenses Associated With Debt Repayments And Refinancing Transactions
ExpensesAssociatedWithDebtRepaymentsAndRefinancingTransactions
0
CY2023Q3 cxw Expenses Associated With Debt Repayments And Refinancing Transactions
ExpensesAssociatedWithDebtRepaymentsAndRefinancingTransactions
100000
cxw Expenses Associated With Debt Repayments And Refinancing Transactions
ExpensesAssociatedWithDebtRepaymentsAndRefinancingTransactions
31316000
cxw Expenses Associated With Debt Repayments And Refinancing Transactions
ExpensesAssociatedWithDebtRepaymentsAndRefinancingTransactions
326000
CY2024Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1181000
CY2023Q3 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
368000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1749000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
343000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
767000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-74000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1153000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30180000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19527000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66802000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
59079000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9084000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5635000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17209000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17957000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
21096000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
13892000
us-gaap Profit Loss
ProfitLoss
49593000
us-gaap Profit Loss
ProfitLoss
41122000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Profit Loss
ProfitLoss
49593000
us-gaap Profit Loss
ProfitLoss
41122000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
96115000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
95183000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3108000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2710000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2777000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3438000
cxw Expenses Associated With Debt Repayments And Refinancing Transactions
ExpensesAssociatedWithDebtRepaymentsAndRefinancingTransactions
31316000
cxw Expenses Associated With Debt Repayments And Refinancing Transactions
ExpensesAssociatedWithDebtRepaymentsAndRefinancingTransactions
326000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1749000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
343000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6019000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1494000
cxw Non Cash Revenue And Other Income
NonCashRevenueAndOtherIncome
7504000
cxw Non Cash Revenue And Other Income
NonCashRevenueAndOtherIncome
2087000
us-gaap Share Based Compensation
ShareBasedCompensation
18720000
us-gaap Share Based Compensation
ShareBasedCompensation
15442000
us-gaap Other Noncash Expense
OtherNoncashExpense
1197000
us-gaap Other Noncash Expense
OtherNoncashExpense
4839000
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-39092000
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-44750000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
3234000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
5691000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
229880000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
209577000
cxw Expenditures For Facility Development And Expansions
ExpendituresForFacilityDevelopmentAndExpansions
7338000
cxw Expenditures For Facility Development And Expansions
ExpendituresForFacilityDevelopmentAndExpansions
5001000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
41634000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
39347000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11901000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6431000
cxw Payments For Proceeds From Other Assets
PaymentsForProceedsFromOtherAssets
-2274000
cxw Payments For Proceeds From Other Assets
PaymentsForProceedsFromOtherAssets
1297000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34797000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39214000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
547000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
125000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8662000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8637000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
47000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
125000000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
593113000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
174754000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
34944000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
119000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
459000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
445000
us-gaap Payments Of Dividends
PaymentsOfDividends
136000
us-gaap Payments Of Dividends
PaymentsOfDividends
131000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
69161000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30531000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-206475000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-214617000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11392000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-44254000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
128956000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
162165000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
117564000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
117911000
cxw Net Establishment Lease Modification Right Of Use Assets And Lease Liabilities
NetEstablishmentLeaseModificationRightOfUseAssetsAndLeaseLiabilities
-56804000
cxw Net Establishment Lease Modification Right Of Use Assets And Lease Liabilities
NetEstablishmentLeaseModificationRightOfUseAssetsAndLeaseLiabilities
566000
us-gaap Interest Paid Net
InterestPaidNet
42958000
us-gaap Interest Paid Net
InterestPaidNet
46809000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26836000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18475000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1477566000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
9543000
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
49267000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
6081000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1443923000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
18954000
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
20393000
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5037000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1447521000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
21096000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
21096000
CY2024Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-1000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
7602000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1476220000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1432408000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
12400000
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
29954000
CY2023Q1 cxw Dividends On Restricted Stock Units
DividendsOnRestrictedStockUnits
6000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4884000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1419732000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
14830000
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
699000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5273000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1439136000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
13892000
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5285000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1458302000
us-gaap Nature Of Operations
NatureOfOperations
<div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ORGANIZATION AND OPERATIONS</span></div></div><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CoreCivic, Inc. (together with its subsidiaries, the "Company" or "CoreCivic") is the nation's largest owner of partnership correctional, detention, and residential reentry facilities and one of the largest prison operators in the United States ("U.S."). Through three segments, CoreCivic Safety, CoreCivic Community, and CoreCivic Properties, the Company provides a broad range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address America's recidivism crisis, and government real estate solutions. As of September 30, 2024, through its CoreCivic Safety segment, the Company operated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> correctional and detention facilities, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">38</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of which the Company owned or controlled via a long-term lease, with a total design capacity of approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">62,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> beds. Through its CoreCivic Community segment, the Company operated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> residential reentry centers, which it owned or controlled via a long-term lease, with a total design capacity of approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> beds. In addition, through its CoreCivic Properties segment, the Company owned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> properties, with a total design capacity of approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> beds.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition to providing fundamental residential services, CoreCivic's correctional, detention, and reentry facilities offer a variety of rehabilitation and educational programs, including basic education, faith-based services, life skills and employment training, and substance abuse treatment. These services are intended to help reduce recidivism and to prepare offenders for their successful reentry into society upon their release. CoreCivic also provides or makes available to offenders certain health care (including medical, dental, and mental health services), food services, and work and recreational programs.</span></p>
CY2024Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1004916000
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1015378000
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1106691000
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1090326000
CY2024Q2 cxw Company Owned Bed
CompanyOwnedBed
2400
CY2024Q3 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
3100000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1004916000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1106691000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
13153000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
12052000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
0
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-434000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
11952000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11597000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
979811000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1083476000
CY2017Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2027-10-15
cxw Charges Associated With The Tender Offer And Redemption
ChargesAssociatedWithTheTenderOfferAndRedemption
31300000
cxw Offer Price For Senior Notes Percentage
OfferPriceForSeniorNotesPercentage
1.01
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2936000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
12073000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
15701000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
262423000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
97995000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
507985000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
105803000
CY2024Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1004916000
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
10100000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
112600000
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
11.16
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
4000000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
59500000
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
14.8
CY2024Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3200000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21096000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13892000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49593000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
41122000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
21096000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13892000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
49593000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
41122000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110271
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113605
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111174
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113919
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110271
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113605
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111174
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113919
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
110971
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
114407
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
111994
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
114605
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9100000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5600000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000
cxw Tax Benefit For Stock Based Compensation Vesting
TaxBenefitForStockBasedCompensationVesting
2600000
cxw Charges For Revaluation Of Deferred Tax Liabilities
ChargesForRevaluationOfDeferredTaxLiabilities
900000
cxw Excise Tax Rate
ExciseTaxRate
0.01
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
400000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
100000
cxw Percentage Of Likelihood Required For Tax Position To Be Measured
PercentageOfLikelihoodRequiredForTaxPositionToBeMeasured
0.50
CY2024Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30180000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19527000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66802000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
59079000
CY2024Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
17817000
CY2023Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
17565000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
47162000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
40243000
CY2024Q3 us-gaap Assets
Assets
2913942000
CY2023Q4 us-gaap Assets
Assets
3105399000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-122939-index-headers.html Edgar Link pending
0000950170-24-122939-index.html Edgar Link pending
0000950170-24-122939.txt Edgar Link pending
0000950170-24-122939-xbrl.zip Edgar Link pending
cxw-20240930.htm Edgar Link pending
cxw-20240930.xsd Edgar Link pending
cxw-ex22_1.htm Edgar Link pending
cxw-ex31_1.htm Edgar Link pending
cxw-ex31_2.htm Edgar Link pending
cxw-ex32_1.htm Edgar Link pending
cxw-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
cxw-20240930_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable